Aurora Spine Corporation Retains PRIA Healthcare to Improve Patient Access to Proprietary Products
December 02 2021 - 6:15AM
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:
ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative
medical devices that improve spinal surgery outcomes, today
announced it has retained PRIA Healthcare to assist in patient
access for its proprietary products, including ZIP® and SiLOTM.
PRIA has 10 years of experience assisting medtech companies and
their products with various payors to improve patient access to new
medical devices. PRIA works with their clients to develop a patient
based prior authorization and appeals program that leverages
clinical evidence and historical coverage decisions to best inform
payors about the individual patient story. PRIA is a
relentless advocate, dedicated to helping patients avoid the
pitfalls of today’s medical insurance systems, helping more
patients gain access to the care most likely to benefit them.
Mr. Clay Schwabe, VP, Business Development of PRIA Healthcare
Management, stated, “From the beginning of our relationship with
Aurora Spine, I’ve been very impressed with their patient-focused
mission, and how it resonates throughout the organization. From
Trent, and his leadership team, to the field executives who work
directly with their physician customers, Aurora is a true partner
to the spine and pain management community. We’re excited to
advocate on the behalf of patients to increase access to the
products and procedures that have the greatest probability of
reducing pain and increasing quality of life.”
Mr. Trent Northcutt, President and Chief Executive Officer of
Aurora Spine, stated, “We are excited to be working with PRIA as
they help Aurora expand its products into the marketplace by
working with many different insurance companies and educating them
on the benefits of emerging medical technologies like those
developed by Aurora. We have confidence in PRIA as they have
successfully assisted other medtech companies that offer products
similar to Aurora’s products.”
About PRIA
Since 2012, PRIA Healthcare has been a national leader in
reimbursement and market access to the healthcare arena throughout
the United States. Led by a team of industry veterans, PRIA is
committed to ensuring the latest medical technologies and
procedures are available to patients both during clinical trials
and through product commercialization. PRIA diligently works to
influence payers to establish patient access to life changing
devices, therapies, treatments, and procedures by leveraging
clinical data, patient, and physician rights.
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal
implant market through a series of innovative, minimally invasive,
regenerative spinal implant technologies. Additional information
can be accessed at www.aurora-spine.com or
www.aurorapaincare.com.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking information that
involves substantial known and unknown risks and uncertainties,
most of which are beyond the control of Aurora Spine, including,
without limitation, those listed under "Risk Factors" and
"Cautionary Statement Regarding Forward-Looking Information" in
Aurora Spine's final prospectus (collectively, "forward-looking
information"). Forward-looking information in this news release
includes information concerning the proposed use and success of the
company’s products in surgical procedures. Aurora Spine cautions
investors of Aurora Spine's securities about important factors that
could cause Aurora Spine's actual results to differ materially from
those projected in any forward-looking statements included in this
news release. Any statements that express, or involve discussions
as to, expectations, beliefs, plans, objectives, assumptions or
future events or performance are not historical facts and may be
forward-looking and may involve estimates, assumptions and
uncertainties which could cause actual results or outcomes to
differ unilaterally from those expressed in such forward-looking
statements. No assurance can be given that the expectations set out
herein will prove to be correct and, accordingly, prospective
investors should not place undue reliance on these forward-looking
statements. These statements speak only as of the date of this
press release and Aurora Spine does not assume any obligation to
update or revise them to reflect new events or circumstances.
Contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Chad Clouse
Chief Financial Officer
(760) 424-2004
www.aurora-spine.com
Adam Lowensteiner
LYTHAM PARTNERS, LLC
Phoenix | New York
Telephone: 646-829-9700
asapf@lythampartners.com
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Apr 2023 to Apr 2024